286 related articles for article (PubMed ID: 28029471)
21. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
De Leon LM; Watson JB; Kelly CR
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
[TBL] [Abstract][Full Text] [Related]
22. Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis.
Chan KS; Lee WY; Yu WL
J Microbiol Immunol Infect; 2016 Dec; 49(6):829-836. PubMed ID: 26850320
[TBL] [Abstract][Full Text] [Related]
23. [Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].
Martínez JV; Raush A; Efrón ED; Zubiaurre I; Pinoni MV; Giorgio PL; Eusebio MJ; Verbanaz SC; Jordan R
Medicina (B Aires); 2019; 79(4):291-294. PubMed ID: 31487251
[TBL] [Abstract][Full Text] [Related]
24. Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
Chen B; Avinashi V; Dobson S
J Infect; 2017 Jun; 74 Suppl 1():S120-S127. PubMed ID: 28646951
[TBL] [Abstract][Full Text] [Related]
25. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile colitis: A clinical review.
Ong GK; Reidy TJ; Huk MD; Lane FR
Am J Surg; 2017 Mar; 213(3):565-571. PubMed ID: 28131326
[TBL] [Abstract][Full Text] [Related]
27. Faecal Microbiota Transplantation as Emerging Treatment in European Countries.
Maida M; Mcilroy J; Ianiro G; Cammarota G
Adv Exp Med Biol; 2018; 1050():177-195. PubMed ID: 29383670
[TBL] [Abstract][Full Text] [Related]
28. Development of fecal microbiota transplantation suitable for mainstream medicine.
Khoruts A; Sadowsky MJ; Hamilton MJ
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
[TBL] [Abstract][Full Text] [Related]
29. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
[TBL] [Abstract][Full Text] [Related]
30. A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.
Trubiano JA; George A; Barnett J; Siwan M; Heriot A; Prince HM; Slavin MA; Teh BW
Leuk Lymphoma; 2015 Feb; 56(2):512-4. PubMed ID: 24828871
[No Abstract] [Full Text] [Related]
31. Current advances related to Clostridium difficile infection.
Kim YG; Jang BI
Indian J Med Res; 2015 Feb; 141(2):172-4. PubMed ID: 25900952
[TBL] [Abstract][Full Text] [Related]
32. [Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
Moscoso F; Simian D; Rivera D; Acuña G; Quera R
Rev Med Chil; 2015 Apr; 143(4):531-5. PubMed ID: 26204547
[TBL] [Abstract][Full Text] [Related]
33. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
[TBL] [Abstract][Full Text] [Related]
34. The Giving Microbiome: Share the Health.
Pitashny M
Isr Med Assoc J; 2016 Oct; 18(10):623-624. PubMed ID: 28471624
[No Abstract] [Full Text] [Related]
35. Oral faecal microbiota transplantation for the treatment of Clostridium difficile-associated diarrhoea in a dog: a case report.
Sugita K; Yanuma N; Ohno H; Takahashi K; Kawano K; Morita H; Ohmori K
BMC Vet Res; 2019 Jan; 15(1):11. PubMed ID: 30616615
[TBL] [Abstract][Full Text] [Related]
36. Practical implementation of faecal transplantation.
Kapel N; Thomas M; Corcos O; Mayeur C; Barbot-Trystram L; Bouhnik Y; Joly F
Clin Microbiol Infect; 2014 Nov; 20(11):1098-105. PubMed ID: 25273614
[TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
Gens KD; Elshaboury RH; Holt JS
J Pharm Pract; 2013 Oct; 26(5):498-505. PubMed ID: 23966282
[TBL] [Abstract][Full Text] [Related]
38. Faecal microbiota transplantation--the Austrian approach.
Kump PK; Krause R; Allerberger F; Högenauer C
Clin Microbiol Infect; 2014 Nov; 20(11):1106-11. PubMed ID: 25274251
[TBL] [Abstract][Full Text] [Related]
39. Fecal microbiota transplantation for treating recurrent Clostridium difficile infection.
OR Manager; 2012 Aug; 28(8):15-8. PubMed ID: 22937601
[No Abstract] [Full Text] [Related]
40. Enterotoxigenic Clostridium perfringens Infection as an Adverse Event After Faecal Microbiota Transplantation in Two Patients With Ulcerative Colitis and Recurrent Clostridium difficile Infection: A Neglected Agent in Donor Screening.
Azimirad M; Yadegar A; Asadzadeh Aghdaei H; Kelly CR
J Crohns Colitis; 2019 Jul; 13(7):960-961. PubMed ID: 30852608
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
